Evidence‑Based Management of Psychotropic Use in Graves Disease

Achieving Euthyroidism Before Psychotropic Initiation

• Restoring and maintaining euthyroid status is the most critical step before starting or continuing psychotropic therapy, because uncontrolled hyperthyroidism itself can produce psychiatric symptoms that mimic primary mental illness. The American College of Endocrinology and the American Association of Clinical Endocrinologists stress that euthyroidism should be achieved promptly in all hyperthyroid patients. 1

Antithyroid Treatment and Monitoring

First‑Line Antithyroid Drug

• Methimazole is the preferred first‑line antithyroid medication; initiate at 0.4–0.8 mg/kg/day with the goal of achieving euthyroidism within approximately 4 weeks. 2

Beta‑Blockade for Symptom Control

• Add a beta‑adrenergic blocker in all patients who are > 60 years old, have a resting heart rate > 90 bpm, or exhibit any adrenergic symptoms, to control tachycardia and other hyperadrenergic effects of excess thyroid hormone. 4

Propylthiouracil (PTU) Restrictions

• PTU is contraindicated as a first‑line agent except in first‑trimester pregnancy or in thyroid storm, because of a high risk of severe hepatotoxicity. 2

Cardiovascular Safety When Combining Psychotropics and Hyperthyroidism

QT‑Prolongation Risk

• Numerous psychotropic drugs can prolong the QT interval and increase the risk of sudden cardiac death, especially in patients who already have cardiac risk factors. 6

Need for ECG Monitoring

• Hyperthyroidism itself heightens cardiovascular risk through adrenergic hyperactivity; therefore, when QT‑prolonging psychotropics are prescribed to these patients, routine electrocardiographic monitoring is recommended to detect potential arrhythmias. 6